论文部分内容阅读
目的:观察依达拉奉、活血通脉胶囊对急性脑出血的治疗效果。方法:将60例脑出血患者随机分为研究组和对照组,研究组在常规治疗的基础上,给予依达拉奉、活血通脉胶囊,2周为1个疗程。4周后研究组和对照组进行疗效判定,并进行统计学分析。结果:研究组治愈率和有效率显著高于对照组(<0.05)。结论:依达拉奉、活血通脉胶囊可明显促进脑出血患者的神经功能康复。
Objective: To observe the therapeutic effect of edaravone and huoxuetongmai capsule on acute cerebral hemorrhage. Methods: Sixty patients with cerebral hemorrhage were randomly divided into study group and control group. The study group was given edaravone and Huoxuetongmai capsules on the basis of routine treatment, and took a course of 2 weeks for one course of treatment. After 4 weeks, the study group and the control group were evaluated for efficacy and statistically analyzed. Results: The cure rate and the effective rate of the study group were significantly higher than those of the control group (<0.05). Conclusion: Edaravone and Huoxuetongmai Capsule can significantly promote the neurological rehabilitation of patients with cerebral hemorrhage.